Results of a multilateral study with Anteovin.
The development of biphasic oral contraceptives is briefly reported and the theoretical basis and advantages of the biphasic method are discussed. The clinical observations referring to Anteovin which have been published until present are summarized and data of 43 authors are statistically analysed. Target specific examinations on the haemostasis and lipid metabolism influencing effect of Anteovin are mentioned. The therapeutic usefulness of biphasic tablet is analysed, the age-related possibilities, the problems of drug interactions and the dermatological advantages of the product are also discussed. With the present study the author wants to prove that the use of the low-dose multiphasic tablets is at present the most acceptable method of oral contraception.
Seregély
G
G
Department for Medical Science, Chemical Works of Gedeon Richter Ltd.
D000293:Adolescent; D000328:Adult; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects; D004341:Drug Evaluation; D004997:Ethinyl Estradiol / Q000009:adverse effects; D019304:Ethinyl Estradiol-Norgestrel Combination; D005260:Female; D006801:Humans; D008875:Middle Aged; D009644:Norgestrel / Q000009:adverse effects
D003278:Contraceptives, Oral, Hormonal; D003280:Contraceptives, Oral, Synthetic; D009644:Norgestrel; D004997:Ethinyl Estradiol; D019304:Ethinyl Estradiol-Norgestrel Combination